Mr. Stephen E. Kemker, M.D. Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 1002 N Shelby St, Suite 1000, Salem, IN 47167 Phone: 812-883-3627 Fax: 812-883-3736 |
News Archive
HedgePath Pharmaceuticals, Inc., a clinical stage biopharmaceutical company that discovers, develops and plans to commercialize innovative therapeutics for patients with cancer, announced today enrollment has commenced in its Phase II(b) SCORING (SUBA-Cap Objective Response in Gorlin's) clinical trial.
Efforts to create nanoparticles that deliver anticancer drugs or imaging agents to tumors while avoiding healthy cells are often stymied by a lack of known tumor targets, that is, molecules found on the surface of malignant cells but not healthy cells.
A new white paper from HealthView Services, the leading provider of retirement health care cost data, highlights a coming retirement health care cost crisis and gap in planning for retirement health care costs.
Alimera Sciences, Inc. (Alimera), a pharmaceutical company that specializes in the research, development and commercialization of prescription ophthalmic pharmaceuticals, announced today that it has received a $25 million advance from Hercules Technology Growth Capital, Inc. (NYSE: HTGC) (Hercules).
› Verified 9 days ago